MedKoo Cat#: 555989 | Name: ZYN57939
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ZYN57939 is RNA polymerase I inhibitor for treating RNA polymerase I-​mediated diseases. ZYN57939 was first reported in CN 104177379 A 20141203 (2014). ZYN57939 showed inhibitory activity with IC50 of 0.855 μM against human HT-​29 cancer cell lines. This product has no formal name at the moment. For the convenience of communication, a temporary code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https://www.medkoo.com/page/naming).

Chemical Structure

ZYN57939
ZYN57939
CAS#1639357-93-9

Theoretical Analysis

MedKoo Cat#: 555989

Name: ZYN57939

CAS#: 1639357-93-9

Chemical Formula: C29H28N6O2S

Exact Mass: 524.1994

Molecular Weight: 524.64

Elemental Analysis: C, 66.39; H, 5.38; N, 16.02; O, 6.10; S, 6.11

Price and Availability

Size Price Availability Quantity
100mg USD 1,450.00 2 Weeks
200mg USD 2,450.00 2 Weeks
500mg USD 3,450.00 2 Weeks
1g USD 4,650.00 2 Weeks
2g USD 7,950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
ZYN57939; ZYN-57939; ZYN 57939; MTR106; MTR 106; MTR-106
IUPAC/Chemical Name
2-((3aR,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide
InChi Key
ZAOCPDXRBFOCQL-YQQQUEKLSA-N
InChi Code
InChI=1S/C29H28N6O2S/c1-16-11-31-20(12-30-16)13-32-28(37)25-26(36)21-7-8-22(17-9-18-14-34(2)15-19(18)10-17)33-27(21)35-23-5-3-4-6-24(23)38-29(25)35/h3-8,11-12,17-19H,9-10,13-15H2,1-2H3,(H,32,37)/t17?,18-,19+
SMILES Code
O=C1C(C(NCC2=NC=C(N=C2)C)=O)=C(SC3=CC=CC=C34)N4C5=NC(C6C[C@@](CN(C)C7)([H])[C@@]7([H])C6)=CC=C15
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 524.64 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Li MZ, Meng T, Song SS, Bao XB, Ma LP, Zhang N, Yu T, Zhang YL, Xiong B, Shen JK, Miao ZH, He JX. Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers. Invest New Drugs. 2021 Oct;39(5):1213-1221. doi: 10.1007/s10637-021-01096-4. Epub 2021 Mar 12. PMID: 33710464. 2: Yan F, Fu Z, Li G, Wang Z. In Silico Investigation of the Molecular Mechanism of PARP1 Inhibition for the Treatment of BRCA-Deficient Cancers. Molecules. 2023 Feb 15;28(4):1829. doi: 10.3390/molecules28041829. PMID: 36838818; PMCID: PMC9961911.